Publisher
American Leprosy Missions
Reference56 articles.
1. Cambau E, Perani E, Guillemin I, Jamet P, Ji B. 1997. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349(9045):103–104.
2. Matsuoka M, Kashiwabara Y, Namisato M. 2000. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Int J Lepr Other Mycobact Dis 68(4):452–455.
3. Maeda S, Matsuoka M, Nakata N, Kai M, Maeda Y, Hashimoto K, Kimura H, Kobayashi K, Kashiwabara Y. 2001. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45(12):3635–3639.
4. Cambau E, Bonnafous P, Perani E, Sougakoff W, Ji B, Jarlier V. 2002. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy. Clin Infect Dis 34(1):39–45.
5. Norman G, Joseph G, Ebenezer G, Rao SP, Job CK. 2003. Secondary rifampin resistance following multi-drug therapy—a case report. Int J Lepr Other Mycobact Dis 71(1):18–21.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply;JAMA Dermatology;2024-07-01
2. Diagnosis of Leprosy through AI-based Mobile Application;2022 OPJU International Technology Conference on Emerging Technologies for Sustainable Development (OTCON);2023-02-08